BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9326194)

  • 41. Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia.
    Pui CH; Boyett JM; Hughes WT; Rivera GK; Hancock ML; Sandlund JT; Synold T; Relling MV; Ribeiro RC; Crist WM; Evans WE
    N Engl J Med; 1997 Jun; 336(25):1781-7. PubMed ID: 9187068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99.
    Mitchell C; Payne J; Wade R; Vora A; Kinsey S; Richards S; Eden T
    Br J Haematol; 2009 Aug; 146(4):424-36. PubMed ID: 19549269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Importance of 6-mercaptopurine dose in lymphoblastic leukaemia.
    Hale JP; Lilleyman JS
    Arch Dis Child; 1991 Apr; 66(4):462-6. PubMed ID: 2031601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.
    Urban C; Benesch M; Lackner H; Schwinger W; Kerbl R; Gadner H
    Klin Padiatr; 1997; 209(4):235-42. PubMed ID: 9293456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute lymphoblastic leukemia: optimizing treatment strategies in children.
    Vora A
    Paediatr Drugs; 2002; 4(6):405-16. PubMed ID: 12038876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy.
    Rivera GK; Raimondi SC; Hancock ML; Behm FG; Pui CH; Abromowitch M; Mirro J; Ochs JS; Look AT; Williams DL
    Lancet; 1991 Jan; 337(8733):61-6. PubMed ID: 1670723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. No impact of high-dose cytarabine and asparaginase as early intensification with intermediate-risk paediatric acute lymphoblastic leukaemia: results of randomized trial TCCSG study L99-15.
    Kato M; Koh K; Manabe A; Saito T; Hasegawa D; Isoyama K; Kinoshita A; Maeda M; Okimoto Y; Kajiwara M; Kaneko T; Sugita K; Kikuchi A; Tsuchida M; Ohara A
    Br J Haematol; 2014 Feb; 164(3):376-83. PubMed ID: 24164537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group.
    Borgmann A; Schmid H; Hartmann R; Baumgarten E; Hermann K; Klingebiel T; Ebell W; Zintl F; Gadner H; Henze G
    Lancet; 1995 Sep; 346(8979):873-6. PubMed ID: 7564672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis of therapy results and prognostic factors in children with acute lymphoblastic leukaemia in Warmia and Mazury region: 17-years experience].
    Badowska W
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1001-7. PubMed ID: 19531816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse.
    Giona F; Testi AM; Rondelli R; Amadori S; Arcese W; Meloni G; Moleti ML; Ceci A; Pillon M; Madon E; Comis M; Pession A; Mandelli F
    Br J Haematol; 1997 Dec; 99(3):671-7. PubMed ID: 9401083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Testicular irradiation in childhood lymphoblastic leukaemia. Medical Research Council Working Party on Leukemia in Childhoods.
    Eden OB; Lilleyman JS; Richards S
    Br J Haematol; 1990 Aug; 75(4):496-8. PubMed ID: 2207001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulmonary function after treatment for acute lymphoblastic leukaemia in childhood.
    Nysom K; Holm K; Olsen JH; Hertz H; Hesse B
    Br J Cancer; 1998 Jul; 78(1):21-7. PubMed ID: 9662245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Periodic acid Schiff reaction in childhood lymphoblastic leukaemia. The Medical Research Council Working Party on Childhood Leukaemia.
    Lilleyman JS; Britton JA; Anderson LM; Richards SM; Bailey CC; Chessells JM
    J Clin Pathol; 1994 Aug; 47(8):689-92. PubMed ID: 7962616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of childhood acute lymphoblastic leukaemia with the BFM regimen.
    Kudva GC; Chandy M; Raghupathy P; Dennison D; Srivastava A; Bhushan V; Singh R
    Indian J Cancer; 1994 Jun; 31(2):78-85. PubMed ID: 7927453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neutropenic enterocolitis in children with acute lymphoblastic leukemia.
    Jain Y; Arya LS; Kataria R
    Pediatr Hematol Oncol; 2000; 17(1):99-103. PubMed ID: 10689720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Mahoney DH; Camitta BM; Leventhal BG; Shuster JJ; Civin CJ; Ganick DJ; Lauer SJ; Steuber CP; Kamen BA
    Cancer; 1995 May; 75(10):2623-31. PubMed ID: 7736409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of treatment in childhood leukaemia. II. Timing and the toxicity of combined 6-mercaptopurine and methotrexate maintenance therapy.
    MacLennan IC; Kay HE; Festenstein M; Smith PG
    Br J Haematol; 1976 Jun; 33(2):179-88. PubMed ID: 1063593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin. The Medical Research Council's Working Party on Childhood Leukaemia.
    Lilleyman JS; Gibson BE; Stevens RF; Will AM; Hann IM; Richards SM; Hill FG
    Br J Haematol; 1997 Jun; 97(3):603-6. PubMed ID: 9207407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
    Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J
    Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.